Senior insider sale
AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$879.7K
50K shares
What this filing means
KIELY JOHN plans to sell 50K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $879.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001628280-26-056733
50K
Shares to sell
$879.7K
Approx. market value
50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
EQUITY COMPENSATION
EQUITY COMPENSATION
5/10/2024
34.71KEQUITY COMPENSATION
EQUITY COMPENSATION
5/5/2021
15.29KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/10/2024 | EQUITY COMPENSATION EQUITY COMPENSATION | 34.71K | — |
5/5/2021 | EQUITY COMPENSATION EQUITY COMPENSATION | 15.29K | — |
| Total | 50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50K
Market value
$879.7K
8/13/2026
Total
Units
50K
Value
$879.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 50K | $879.7K | NASDAQ | Planned |
| Total | 50K | $879.7K | ||